Analysis of the Curative Effect of Clindamycin in the Treatment of Mycoplasma Pneumonia in Children
HE Tiefe
Abstract
HE Tiefe
Abstract
Objective To investigate and study the clinical efficacy of clindamycin in the treatment of mycoplasma pneumonia in children. Methods The clinical data of 88 children with mycoplasma pneumonia admitted in our hospital from January 2009 to January 2013 were selected as the subjects. And the children were randomly divided into the observation group and the control group with 44 children in each. The control group was treated by azithromycin, and the observation group was treated by clindamycin on the basis of azithromycin. The efficacies of the two groups of children were counted and compared. Results The efficacies of the groups showed that the total effective rate and markedly effective rate of the observation group was 95.5%, 61.3%, respectively, higher than 81.8%, 36.3% of the control group, respectively, the differences were statistically significant(P0.05). The incidence of adverse reactions of the observation group was 6.8%, and that of the control group was 9.1%, the difference was not statistically significant(P0.05). Conclusion Clindamycin is quite effective in the treatment of children with mycoplasma pneumonia. The effect of clindamycin combined with azithromycin is much better than that of azithromycin, and it is worthy of promotion and application in clinical practice.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate and study the clinical efficacy of clindamycin in the treatment of mycoplasma pneumonia in children. Methods The clinical data of 88 children with mycoplasma pneumonia admitted in our hospital from January 2009 to January 2013 were selected as the subjects. And the children were randomly divided into the observation group and the control group with 44 children in each. The control group was treated by azithromycin, and the observation group was treated by clindamycin on the basis of azithromycin. The efficacies of the two groups of children were counted and compared. Results The efficacies of the groups showed that the total effective rate and markedly effective rate of the observation group was 95.5%, 61.3%, respectively, higher than 81.8%, 36.3% of the control group, respectively, the differences were statistically significant(P0.05). The incidence of adverse reactions of the observation group was 6.8%, and that of the control group was 9.1%, the difference was not statistically significant(P0.05). Conclusion Clindamycin is quite effective in the treatment of children with mycoplasma pneumonia. The effect of clindamycin combined with azithromycin is much better than that of azithromycin, and it is worthy of promotion and application in clinical practice.
Key concepts: Azithromycin, Medicine, Clindamycin, Mycoplasma pneumonia, Mycoplasma, Incidence (geometry), Internal medicine, Pneumonia